PRIME-CKD

Less pills, better pills
Personalized Drug Response:
Implementation and Evaluation in CKD

Read more ›

About Prime-CKD

Chronic Kidney Disease (CKD) is one of the major causes of death in high income countries and its prevalence is growing rapidly. New therapies for the treatment of CKD have shown clear efficacy at a population level. Yet, individual patients respond differently with many patients showing suboptimal efficacy. This indicates that a ‘one size fits all’ approach is no longer sustainable. Currently there are no validated biomarkers (i.e. signal-substances that can be measured in blood or urine) in patients with CKD that aid in guiding optimal therapy for individual patients. Furthermore, there remains a large gap between biomarker research and actual implementation of biomarker based care in daily clinical practice.

“Individual and optimal treatment for every kidney patient; that is what we aim for.”

What is our objective?

The researchproject PRIME-CKD (Personalized drug Response: IMplementation and Evaluation in Chronic Kidney Desease) has a unique advantage to address the challenge we are facing as it builds on recent discoveries of new biomarkers to help guide optimal treatment to individual patients. The research must lead to new therapies for the treatment of CKD.

Read more
Objective of Prime CKD

Latest News

, , ,

PRIME-CKD members Heerspink and Gorriz involved in promising SMART study

At the ASN conference, clinical pharmacologist Hiddo L. Heerspink of the University Medical Center Groningen presented remarkable findings from the SeMaglutide and Albuminuria Reduction Trial in Obese Individuals..
Read more
, ,

PRIME-CKD @ASN

Many of our consortium partners will be attending and participating in ASN this week. There will be several poster presentations by PhD students from UMCG, along with oral presentations by our partners. Notably, Hiddo Lambers Heerspink will be presenting....
Read more
, , ,

Publication BePRECISE in Nature Magazine

An important publication in the field of precision medicine, to which PRIME-CKD PI Maria Gomez from Lund University contributed, has been published in Nature Medicine. The aim of this publication is to standardize the reporting of research...
Read more

Prime-CKD news in your mailbox

We can provide you with the latest information via RSS. Click the RSS icon if your browser supports RSS feeds (Chrome or addons).

Or use url https://www.prime-ckd.com/feed in a RSS-reader or an e-mail rss-feed.

Our partners

Copyright © 2024 - Webtail for UMCG Clinical Pharmacy and Pharmacology ]